Virtual Reality: The VR group will be exposed to a unified 15-minute VR video via phone using a VR device and goggles after receiving routine standard care. A 360˚ video with an immersive audio-visual environment describing pre-operative and post-operative experience on the day of the surgery will be provided, by which they can get accustomed to the environment and procedures associated with the surgery. Background audio will be provided through headsets, and the video will be directed by a neurosurgeon filmed using a Max 360 action VR camera. In the video, actors, neurosurgeons, and nurses will re-enact a typical day for a mock patient undergoing surgery, plus routine post-operative care, including the post-operative immediate recovery room and rehabilitation care by neurosurgeons, psychologists, and physiotherapists in the ward. Patients are allowed to move around freely so that they can experience all aspects of the virtual space, and are encouraged to ask questions at the end.
Study summary
The aim of this research study is to evaluate the impact of immersive VR exposure on preoperative anxiety and pain. Additionally, to assess whether VR intervention would significantly alleviate pain and anxiety levels of patients undergoing complex spinal surgeries. Investigators hypothesize that the application of pre-operative VR-based intervention will alleviate anxiety and pain both pre- and post-operatively when it is used as treatment to complement standard care compared to standard routine care alone, and that it may lead to better outcomes and higher satisfaction in patients.
Eligibility
Sex
ALL
Min age
25 Years
Max age
70 Years
Healthy volunteers
No
Inclusion Criteria:
* Adult patients between 25-70 years old, undergoing an elective spinal surgery.
* Patient's admission prior to surgery day (at least 1 day).
* Expected hospital stay - 2 days.
* Capable of providing informed consent and participate in the study follow-up questionnaire.
* Patients speak Polish.
Exclusion Criteria:
* Congestive heart failure, hypertension and anti-hypertensive medications
* Adrenal insufficiency
* Alcohol addiction (evaluated by CAGE/AUDIT) and substance addiction (evaluated by DUDIT)
* Cognitive impairment (evaluated by MMSE, MoCA)
* Cerebrovascular diseases, ophthalmological diseases (strabismus, diplopia, retina degeneration, glaucoma), neurological conditions (epilepsy or seizure, dementia, vertigo, dizziness, motion sickness) - evaluated by: history taking, examination, vision test (Ishihara test), Simulator Sickness Questionnaire
* Auditory impairment
* Psychiatric illness (schizophrenia, bipolar disorder, psychotic depression) - (evaluated by MINI questionnaire)
* Patients with neuropathic pain
* Use of sedative drugs, anti-depressants, anxiolytics, and anti-epileptic drugs
* Intracranial functional lesions (patients after TBI (Traumatic Brain Injury), cognitive or executive dysfunction)
* Patient with high risk due to major and emergency operations
* Claustrophobia
* GCS \< 15
Primary outcome measure(s)
Stress (STAI-S) and Pain (VAS) — 24 hours postoperatively The Primary outcome for this trial is the change in the intensity of pre-operative anxiety measured by the State-Trait Anxiety Inventory (STA-I) scale and pain measured by visual Analogue Scale (VAS). These outcomes will be measured pre-operatively on the day before surgery. Measurements will be made again post-operatively - within 24 hours. Pre-operative and post-operative STAI-S and VAS will be compared for data analysis.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
